BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 16688747)

  • 1. Incidence of impalpable carcinoma of the prostate and of non-malignant and precarcinomatous lesions in Greek male population: an autopsy study.
    Stamatiou K; Alevizos A; Agapitos E; Sofras F
    Prostate; 2006 Sep; 66(12):1319-28. PubMed ID: 16688747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of impalpable prostate adenocarcinoma and precancerous conditions in Greek male population: an autopsy study.
    Stamatiou K; Alevizos A; Perimeni D; Sofras F; Agapitos E
    Prostate Cancer Prostatic Dis; 2006; 9(1):45-9. PubMed ID: 16314890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and pathological characteristics of prostate cancer in Italy: a contribution to the screening debate.
    Picone GM; Pizzi C; Quartuccio A; Scognamiglio G; Tauchmanova L; Di Maio M; Cifarelli P; Contegiacomo A
    Cancer Detect Prev; 2006; 30(5):455-8. PubMed ID: 17067751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoplastic and borderline lesions of the prostate: autopsy study and epidemiological data.
    Silvestri F; Bussani R; Pavletic N; Bassan F
    Pathol Res Pract; 1995 Sep; 191(9):908-16. PubMed ID: 8606873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Premalignant and benign lesions in nodules of adenomatous hyperplasia].
    Miján Ortiz JL; Fernández Rodríguez A; Fernández Ruiz PL; de la Fuente Serrano A; Nogales Fernández F; Zuluaga Gómez A
    Arch Esp Urol; 1996 Sep; 49(7):684-7. PubMed ID: 9020004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preneoplastic lesions of the prostate-clinical, pathological and molecular biological aspects.
    Nasir A; Copeland J; Gillespie JW; Chughtai OR; Andrawis R; Kaiser HE; Manyak MJ
    In Vivo; 2002; 16(6):557-66. PubMed ID: 12494901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do clinically insignificant tumors of the prostate exist?
    Stamatiou K; Alevizos A; Mariolis A; Spiliopoulou C; Alevizou A; Bovis K; Sofras F
    Urol Int; 2008; 81(4):379-82. PubMed ID: 19077395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations among benign prostate hypertrophy, atypical adenomatous hyperplasia and latent carcinoma of the prostate.
    Stamatiou K; Alevizos A; Natzar M; Mihas C; Mariolis A; Michalodimitrakis E; Sofras F
    Asian J Androl; 2007 Mar; 9(2):229-33. PubMed ID: 16751999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic atrophy: an autopsy study of a histologic mimic of adenocarcinoma.
    Billis A
    Mod Pathol; 1998 Jan; 11(1):47-54. PubMed ID: 9556422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premalignant lesions of prostate and their association with nodular hyperplasia and carcinoma prostate.
    Rekhi B; Jaswal TS; Arora B
    Indian J Cancer; 2004; 41(2):60-5. PubMed ID: 15318010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A theoretical rationale on the histogenesis of premalignant lesions and early carcinoma of the prostate.
    Botticelli AR
    Pathologica; 1994 Apr; 86(2):128-41. PubMed ID: 7524011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of prostate carcinoma and its precursor in Hungary: an autopsy study.
    Soos G; Tsakiris I; Szanto J; Turzo C; Haas PG; Dezso B
    Eur Urol; 2005 Nov; 48(5):739-44. PubMed ID: 16203079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions.
    Goel T; Garg S
    Urol Int; 2009; 82(3):286-90. PubMed ID: 19440015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic characterisation of prostate diseases in Port Harcourt.
    Obiorah CC; Nwosu SO
    Niger Postgrad Med J; 2009 Jun; 16(2):158-61. PubMed ID: 19606198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prostate gland-transition zone lesions. Etiology, growth regulation, growth factors, genetic changes].
    Pavelić J; Zeljko Z
    Lijec Vjesn; 2002; 124(6-7):211-9. PubMed ID: 19658339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between atypical adenomatous hyperplasia (AAH), prostatic intraepithelial neoplasia (PIN) and prostatic adenocarcinoma.
    Helpap B; Bonkhoff H; Cockett A; Montironi R; Troncoso P; Waters D; Bostwick D
    Pathologica; 1997 Jun; 89(3):288-300. PubMed ID: 9270265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship of prostatic carcinoma of the peripheral zone with glandular atrophy and prostatic intraepithelial neoplasia].
    Algaba Arrea F; Trias Puig-Sureda I; López Duesa L; Rodríguez-Vallejo JM; González-Esteban J
    Actas Urol Esp; 1997 Jan; 21(1):40-3. PubMed ID: 9182444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frequency and differential diagnosis of cribriform structures of the prostate].
    Mehlhorn J
    Zentralbl Pathol; 1991; 137(4):349-54. PubMed ID: 1722706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problems of so-called atypical hyperplasia of the prostate].
    Mehlhorn J
    Z Urol Nephrol; 1987 Jul; 80(7):379-85. PubMed ID: 2444040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of incidental prostate cancer in the general population: a study of healthy organ donors.
    Yin M; Bastacky S; Chandran U; Becich MJ; Dhir R
    J Urol; 2008 Mar; 179(3):892-5; discussion 895. PubMed ID: 18207193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.